Lavanya Ramnath is a regulatory affairs professional with over eight years of experience in diabetes and cardiovascular technologies, spanning medical devices, software, and digital health. Having held roles at Insulet, Abbott, BD, and Medtronic, she has led regulatory strategy and submissions, including 510(k), PMA, IDE, and EU MDR, across the full product lifecycle and multiple global markets. She also serves the profession through RAPS and TOPRA judging, mentoring, and regulatory education contributions.